Honey & Nigella Sativa Trial Against COVID-19

• Status: Completed
• Trial end date: 2020-08-30
• Target enrollment: 0
• Participant gender: All

Summary

To evaluate the effectiveness of Nigella Sativa and honey stirred in 250 ml of distilled water 12 hourly till patient becomes asymptomatic or a maximum of 14 days with standard hospital care versus standard hospital care alone with placebo capsule and 250 ml water, in clearing the COVID-19 nucleic acid from throat and nasal swab, lowering disease detrimental effects on HRCT chest/X-ray and severity of symptoms along with duration of hospital stay till day 14th day of follow up and 30 days mortality (primary outcomes).

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Sheikh Zayed Federal Postgraduate Medical Institute; Sohaib Ashraf
• Collaborator: Mayo Hospital Lahore

Criteria

Inclusion Criteria:

• Confirmed SARS-CoV-2 (COVID-19) infection by a positive test result with SSC-2 score> 5

• Patients admitted in Corona centers

Exclusion Criteria:

• Participants not giving consent.

• Pregnant and lactating females.

• History of allergy to any drug being administered in this study

• Severely terminally ill patients

• Patients on Nil Per Oral